Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Sep;96(37):e7978.
doi: 10.1097/MD.0000000000007978.

Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease

Affiliations
Comparative Study

Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease

Bi Xing Ye et al. Medicine (Baltimore). 2017 Sep.

Abstract

To determine the relationship between baseline impedance levels and gastroesophageal reflux, we retrospectively enrolled 110 patients (54 men and 56 female; mean age, 51 ± 14 years) with suspected gastroesophageal reflux disease (GERD) who underwent 24-h multichannel intraluminal impedance and pH monitoring. Patients were stratified according to symptom (typical or atypical) and reflux types (acid reflux, nonacid reflux [NAR], or no abnormal reflux). Mean nocturnal baseline impedance (MNBI) were measured 3 cm (distal esophagus) and 17 cm (proximal esophagus) above the lower esophageal sphincter. Median distal esophageal MNBI was lower in the acid reflux group (1244 Ω; 647-1969 Ω) than in the NAR (2586 Ω; 1368-3666 Ω) or no abnormal reflux groups (3082 Ω; 2495-4472 Ω; all P < .05). Distal MNBI were negatively correlated with DeMeester score and acid exposure time. Atypical symptoms were more frequently associated with NAR than typical symptoms (P < .01). Among patients with positive symptom-association probability (SAP) for NAR, median proximal MNBI tended to be lower in patients with typical symptoms (median, 3013 Ω; IQR, 2535-3410 Ω) than in those with atypical symptoms (median, 3386 Ω; IQR, 3044-3730 Ω, P = .05). Thus, atypical GERD symptoms were more likely to be associated with NAR. The mucosal integrity of the proximal esophagus might be relatively impaired in GERD patients with typical symptoms for NAR.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

Figure 1
Figure 1
MNBI at the distal and proximal esophagus among different reflux groups. (A) Proximal esophageal MNBI do not differ among the study groups (P > .05). (B) Distal MNBI are lower in patients with acid reflux than in patients with NAR and nonreflux subjects (all P < .05). No difference in MNBI is present between patients with NAR and nonreflux subjects (P > .05). MNBI = mean nocturnal baseline impedance, NAR = nonacid reflux.
Figure 2
Figure 2
Distal MNBI are negatively correlated with (A) AET (r = −0.48, P < .01) and (B) DeMeester score (r = −0.37, P < .01). AET = acid exposure time, MNBI = mean nocturnal baseline impedance.
Figure 3
Figure 3
Relationship among typical and atypical symptoms of GERD, and reflux types. GERD = gastroesophageal reflux disease, NAR = nonacid reflux, SAP = symptom-association probability.
Figure 4
Figure 4
Correlation between symptom-reflux association and MNBI. (A) A trend of lower proximal MNBI is seen in patients with typical symptoms and positive SAP for NAR compared with patients with atypical symptoms and positive SAP for NAR (P = .05). (B) No differences in distal MNBI are seen between patients with typical and atypical symptoms with positive SAPs for acid reflux, and between patients with typical and atypical symptoms with positive SAPs for NAR (P > .05). MNBI = mean nocturnal baseline impedance, NAR = nonacid reflux, SAP = symptom-association probability.

Similar articles

Cited by

References

    1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global, evidence-based consensus paper. Z Gastroenterol 2007;45:1125–40. - PubMed
    1. El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014;63:871–80. - PMC - PubMed
    1. Sidhwa F, Moore A, Alligood E, et al. Diagnosis and treatment of the extraesophageal manifestations of gastroesophageal reflux disease. Ann Surg 2016;265:63–7. - PubMed
    1. Orlando RC. The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Pract Res Clin Gastroenterol 2010;24:873–82. - PMC - PubMed
    1. Futagami S, Iwakiri K, Shindo T, et al. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol 2010;45:413–21. - PubMed

Publication types